Cardiovascular Longevity: ApoB, Lp(a) and the New Metrics That Actually Predict Heart Disease
June 18, 2027
3:45 pm – 4:15 pm
Room 1
LDL-C is no longer the most important number on your lipid panel, and the clinical evidence for ApoB, Lp(a) and coronary calcium scoring is reshaping how cardiovascular risk is understood and managed. Advance your ability to apply the metrics that actually predict long-term heart disease risk. Take away specific solutions to:
- Master the clinical case for ApoB and Lp(a) as superior predictors of cardiovascular risk over conventional LDL-C measurement
- Identify where coronary calcium scoring and PCSK9 inhibitors fit within a modern cardiovascular longevity strategy
- Adopt a more precise, evidence-based framework for assessing and reducing your long-term heart disease risk
Achieve a far clearer picture of your cardiovascular future, and act on the numbers that genuinely matter.